| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.07 |